Palliative treatment of obstructive jaundice from advanced tumour of the distal bile duct is controversial. The aim of this study was to compare the clinical outcomes and costs between endoscopic stent insertion and surgery. METHODS: The clinical data for 116 patients treated with either endoscopic plastic stenting (65 patients) or surgical bypass (51 patients) were reviewed and analysed. RESULTS: No significant difference was found between the two groups in terms of the length of hospital stay, survival time, cost, effectiveness, and early complications. However, late complications were significantly more common in the stenting group (p = 0.007). Jaundice recurred in 15 stented patients at a median time of 3 months due to stent blockage, and one surgical patient had recurrent jaundice from anastomosis stricture. Late gastric outlet obstruction occurred in one of 36 surgical patients who did not undergo prophylactic gastroenterostomy and one of 65 stented patients developed this complication. CONCLUSION: Both techniques are equally effective in biliary drainage, but stenting has a higher rate of recurrent jaundice. We recommend surgery for patients with low surgical risks and endoscopic stent in those with a short life expectancy or those unfit for surgery. [Asian J Surg 2005;28(4):262-5] 
Introduction
Malignant distal bile duct obstruction is caused by carcinoma of the pancreas, distal common bile duct, ampulla of Vater, gallbladder or duodenum. Unfortunately, most patients are elderly and/or have an advanced stage of disease at the time of diagnosis, and are unsuitable for curative resection.
Palliative treatment is usually performed to relieve the jaundice. Biliary-enteric surgical bypass has been the treatment of choice for palliation of obstructive jaundice for many years. The introduction of a minimally invasive endoscopic stenting technique by Soehendra and Reynders-Frederix has Endoscopic Stenting Versus Surgical Bypass in Advanced Malignant Distal Bile Duct Obstruction: Cost-effectiveness Analysis provided a new option for clinicians, and this has become a very popular procedure in the management of obstructive jaundice. 1 The choice between surgery and endoscopic drainage is a matter of personal preference and availability of alternative techniques. Comparative studies from Western countries have shown a similar efficacy between endoscopic drainage and surgical treatment. However, there are no data to support these findings in developing countries, where costeffectiveness has to be considered. This study aimed to compare the clinical outcomes, complications, survival time and cost utility of endoscopic plastic stent drainage and surgical drainage.
070/2001 ■ STENT OR SURGERY IN MALIGNANT BILIARY OBSTRUCTION ■

Patients and methods
The medical records of 116 patients with a clinical diagnosis of primary malignant obstruction of the distal bile duct who were palliatively treated at Songklanagarind Hospital between January 1992 and December 2003 with endoscopic plastic stent drainage (straight double-flapped polyethylene, 10 Fr) or biliary-enteric surgical bypass were reviewed. Data were obtained from admission charts, follow-up clinical notes and the population database of the Ministry of the Interior (for patients who were lost to follow-up).
Selection of either endoscopic drainage or surgery was at the discretion of the attending physician. The type of surgical drainage procedure was determined by the operative findings. Endoscopic stent drainage was performed as described elsewhere. 2 The diagnosis of malignancy was made by histopathology or the clinical course of the patients when histopathological diagnosis was not available.
Outcome measures were defined as follows: effectiveness of biliary drainage was the dropping of serum bilirubin to less than 50% of the initial value; hospital stay was the number of days in hospital from admission to first discharge; survival time was the time from the procedure until the death of the patient; complications were divided into two groups, early (during the time the patient remained in the hospital) and late (after discharge); mortality refers to deaths that were procedure-related or which occurred within 30 days from the time of the procedure; cost refers to hospital billing (initial cost refers to the billing for the first admission, while total cost refers to the total expense incurred from the first admission until death).
Results are reported as mean ± standard error of the mean. The 95% confidence interval (CI) was also calculated. A p value of less than 0.05 was considered to be significant. The probability of survival was estimated using the Kaplan-Meier method.
Results
Of the 116 patients, there were 68 males and 48 females, with a mean age of 61.1 ± 1.2 years (range, 37-85 years). Tumours were located in the pancreas (67), distal common bile duct (39), ampulla of Vater (6), gallbladder (3) and duodenum (1). Sixty-five patients were treated with endoscopic stent drainage and 51 with a surgical bypass. The surgical procedures performed in the surgical group were choledochojejunostomy in 31 patients, cholecystojejunostomy in 16 and choledochoduodenostomy in four. Table 1 shows the characteristics of the patients prior to treatment. There was no notable difference in age, gender, initial total bilirubin, alkaline phosphatase and albumin levels between the two groups. The clinical outcomes are shown in Table 2 . The surgical group seems to have had a longer hospital stay and greater effectiveness of biliary drainage, but a shorter 
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■ SUNPAWERAVONG et al ■ mean survival time and lower overall expense than the stenting group, but the differences were not significant. The details of complications and mortalities are shown in Table 3 . Early complications occurred in seven stented patients and seven surgical patients. Recurrent jaundice from stent blockage was the most common late complication in patients treated by the endoscopic method (22 blockages in 15 patients), with a median patency time of 3 months (range, 1-9 months). There were only three late complications in the surgical group, which was a significantly lower rate than in the stent group (p = 0.007).
Gastrojejunostomy during biliary-enteric bypass was performed in 15 patients as a prophylactic measure against duodenal obstruction. One patient in the surgical group who had not undergone gastrojejunostomy developed symptoms of duodenal obstruction due to tumour invasion and required gastrojejunostomy to relieve the symptoms. One of the patients treated with stent insertion developed duodenal obstruction during the follow-up period. The Figure shows the survival curves for the two groups; there was no significant difference.
Discussion
Most patients who are diagnosed with obstructive jaundice due to malignant obstruction are not candidates for curative surgical resection. Palliation by endoscopic stent drainage, surgical bypass and percutaneous drainage are the main treatment options available to the physician dealing with these patients. The selection of treatment is influenced by the availability of the options and local expertise. [3] [4] [5] Few randomized trials comparing endoscopic stenting and surgical bypass have been reported. One early study by Shepherd et al showed the same survival rate, but the stenting group had shorter hospital stays with a higher readmission rate. 6 Andersen et al found the same. 7 Smith et al confirmed this, but also noted that surgical treatment resulted in a higher rate of early complications, while stenting led to more recurrent jaundice. 8 In our study, there was no significant difference in early complications between the two methods of treatment. However, since this was not a randomized study, one must note the possibility of selection bias in that lower-surgical-risk patients might have been treated using surgery while those at higher surgical risk or a more advanced stage of disease were offered endoscopic stenting. There was no difference between the groups in the efficacy of biliary drainage, length of hospital stay or survival rates. The stenting group had more late complications than the surgical group due to the problem of stent 
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■ STENT OR SURGERY IN MALIGNANT BILIARY OBSTRUCTION ■ blockage. Western studies found that surgical treatment had higher initial and total hospital costs than endoscopic stenting. 9, 10 Our study showed a slightly higher initial cost and total cost for the endoscopic stent than for surgery, but no statistical significance was detected.
A review by Wattanapa and Williamson found that 17% of patients who underwent biliary bypass alone eventually developed a duodenal obstruction at a mean of 8.6 months later and required subsequent gastric bypass. 11 Lillemore et al randomized unresectable periampullary cancer patients and showed that prophylactic gastrojejunostomy significantly decreased the incidence of late gastric outlet obstruction (0/44 versus 8/43 who did not have the procedure). 12 The median time between initial exploration and therapeutic intervention was 2 months. They suggested that gastroenterostomy be undertaken at the time of the initial biliary bypass, as this approach did not increase the mortality rate and the substantial risk of mortality pertaining to a subsequent operation could be avoided. Our series, however, showed that only two of 101 patients (2%) who did not have a prophylactic gastroenterostomy later developed duodenal obstruction. This difference might be because patients were diagnosed at a more advanced stage in our series, as judged from the shorter survival time in this study than those reported by Wattanapa and Williamson 11 and Lillemore et al. 12 Stent blockage was a major problem, occurring in 23% of the patients in this study. The median patency time of 3 months with a range of 1-9 months is similar to those found in other reports. [6] [7] [8] [9] [10] The stent was changed only in the event of recurrent jaundice or cholangitis in the cases in this study, while others reported that the stent was routinely changed every 3-6 months. 13, 14 The effect of these different approaches in terms of cost-effectiveness, however, is not clear. A selfexpandable metallic stent, with a larger diameter compared with a plastic stent when fully expanded, may decrease the incidence of stent blockage. There have been a few randomized trials showing more benefit from metallic than plastic stents in reducing this problem. [15] [16] [17] The major drawback of metallic stents is their high cost, and another study indicates that metallic stents are cost-effective only in patients who survive for longer than 6 months. 14 In conclusion, endoscopic stenting and surgical bypass are equal in terms of effectiveness in biliary drainage. However, the surgical approach seems to result in less recurrent jaundice than the stent approach. We recommend surgery for patients at low surgical risk, and an endoscopic stent for those with a short life expectancy or who are unfit for surgery in a setting such as our country, where reasonable cost-effectiveness must be considered.
